Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000319756 | SCV000343231 | uncertain significance | not provided | 2016-07-18 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001085217 | SCV001009898 | likely benign | Walker-Warburg congenital muscular dystrophy | 2024-01-24 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000319756 | SCV002543948 | likely benign | not provided | 2022-06-01 | criteria provided, single submitter | clinical testing | FKRP: BP4, BP7 |
Ambry Genetics | RCV002348018 | SCV002650175 | benign | Cardiovascular phenotype | 2021-08-04 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Natera, |
RCV001828260 | SCV002088926 | likely benign | Autosomal recessive limb-girdle muscular dystrophy type 2I | 2020-11-29 | no assertion criteria provided | clinical testing | |
Prevention |
RCV004535418 | SCV004713477 | likely benign | FKRP-related disorder | 2022-06-10 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |